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Abstract
Background—Respiratory diseases encompass a number of complex disorders that constitute a 
major cause of both morbidity and mortality worldwide with a major burden to the afflicted as 
well as the health care systems that care for them. Although the prevalence of chronic respiratory 
diseases (CRDs) has been decreasing in industrialized countries due to a decreasing number of 
smokers and stricter laws aimed at reducing exposure to secondhand smoke (SHS), the burden of 
CRDs in developing world populations is expected to worsen due to communicable disease 
prevention programs, aging populations, environmental air pollution, and continued tobacco 
smoke exposure. Although tobacco smoking has been shown to be significantly associated with 
many CRDs, evidence linking SHS exposure to different CRDs is mixed, especially with low 
levels of SHS exposure.
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Methods—The National Health and Nutrition Examination Survey (NHANES) is a series of 
studies designed to assess the health and nutritional status of non-institutionalized adults and 
children in the United States (U.S.). In addition to being used to monitor the health of the U.S. 
population, NHANES data allow for research into prevalent health problems and their risk factors 
in the population, such with CRDs and SHS exposure. NHANES data can be utilized to explore a 
variety of issues related to the assessment of SHS exposure and its association to respiratory 
symptoms and illnesses.
Results—First, we provide a brief review of NHANES including its strengths and limitations. 
We then provide a summary of the variables and publically available population based data that 
can be used to study associations between SHS exposure and CRD symptoms, testing and 
diagnoses.
Conclusion—Rich and cost effective, NHANES data provide a unique opportunity for research 
into the risk factors for CRDs in the U.S. population, particularly into the possible health effects of 
low levels of SHS exposure.
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Introduction
Respiratory diseases are complex disorders that constitute a major cause of both morbidity 
and mortality worldwide. For example, the top five respiratory diseases account for 17.4% 
of all deaths and 13.3% of all Disability-Adjusted Life Years according to the World Health 
Organization [1]. Additionally, respiratory diseases are a major burden to the health care 
system; in 2006, respiratory diseases were the third most common diagnosis for emergency 
department visits in the United States (U.S.) and a major cause of hospital admissions in the 
USA [2,3]. The burden of chronic respiratory diseases (CRDs), such as asthma, chronic 
bronchitis, emphysema, allergic rhinitis, and chronic sinusitis, has been decreasing in 
industrialized countries due to decreasing numbers of smokers and the passage of laws 
aimed at reducing exposure to secondhand smoke (SHS) [4-6]. However, in developing 
world populations, the burden of CRDs is expected to worsen due to aging populations, 
environmental air pollution, continued tobacco smoke exposure, and communicable disease 
prevention programs [4-6].
Although tobacco smoking has been shown to be significantly associated with many CRDs, 
evidence linking secondhand tobacco smoke exposure to different CRDs is inconsistent, 
especially with low levels of SHS exposure [4,6-10]. Research on the health effects of SHS 
exposure pose a particular challenge due to the tools used to measure SHS exposure. For 
example, it has been shown that self-report of SHS exposure can be inaccurate, frequently 
underestimating SHS exposure [11]. One type of measurement tool designed to increase the 
accuracy of a subject’s SHS exposure, particularly at low levels of SHS exposure, are 
biomarkers of tobacco smoke exposure. Thus, robust studies investigating associations 
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between SHS exposure and CRDs frequently include both self-report as well as objective 
biomarker measurements to verify or quantify such exposures.
The National Health and Nutrition Examination Survey (NHANES) is a series of studies 
designed to assess the health and nutritional status of non-institutionalized adults and 
children in the United States. Conducted by the National Center for Health Statistics 
(NCHS), the program of studies has focused both on different populations as well as a 
variety of health measurements to meet emerging needs. In addition to being used to monitor 
the health of the U.S. population, NHANES data provides a unique opportunity for research 
into prevalent health problems and their risk factors in the population, such with CRDs and 
SHS exposure. NHANES data can be utilized to explore a variety of issues related to the 
assessment of SHS exposure and its relation to health outcomes.
The objective of this review is to provide a general description of currently accessible and 
future datasets regarding assessment of SHS exposure and the symptoms, tests, and 
diagnoses of CRDs as part of NHANES III and the continuous NHANES 1999-2010. After 
a brief description of the NHANES, we will provide summaries of the data and the variables 
that can be used to study symptoms, diagnoses and tests of CRDs and assessment of SHS 
exposure.
Materials and Methods
Use of large-scale population based surveys is a common practice for epidemiologic 
investigation. In these surveys, demographic characteristics, self-report survey questions, 
physical examination characteristics, as well as laboratory measurements are frequently used 
to investigate the complex relationships that affect the development of disease in both 
individuals and populations. The NHANES is a widely used resource that combines a wide 
array of such variables that are available for analysis, with many variables that are publically 
accessible. We provide a general review of NHANES, summaries of NHANES data and the 
variables that can be used to investigate relationships between SHS exposure and variables 
regarding CRDs in the U.S. population.
The National Health and Nutrition Examination Surveys (NHANES)
The National Health and Nutrition Examination Survey (NHANES) is a program of studies 
designed to assess the health and nutritional status of adults and children in the United 
States. The NHANES program began in the early 1960s. The program has been conducted 
as a series of surveys on different health topics and population groups. In 1999, the survey 
became a continuous program with a changing focus on a variety of health and nutrition 
measurements. Each year a nationally representative sample of about 5,000 persons who are 
located in counties across the country are interviewed for demographic, socioeconomic, 
dietary, and health-related questions.
The studies originally included a limited array of survey questions and physical examination 
variables. After much iteration, the study has expanded to include a plethora of 
demographic, survey, physical examination, and laboratory variables allowing for 
comprehensive analyses of cross-sectional data. Highly trained medical personnel 
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administer the examination component which consists of medical, dental, and physiological 
measurements, as well as laboratory tests.
The two most recent incarnations of the NHANES series, the NHANES III and the 
continuous NHANES, include serum biomarker data of tobacco smoke exposure which 
create both significant advantages as well as complications for research using data from this 
study. We review both NHANES studies regarding survey design and data available.
The NHANES III employed a complex sampling strategy to obtain a representative sample 
of African-Americans, non-Hispanic whites, and Mexican-Americans ages two months and 
older. Household interviews were obtained on nearly 34,000 family members from 
approximately 20,000 randomly selected households in 81 U.S. counties. Physical 
examinations were conducted at mobile examination centers where blood samples were 
obtained. The 1999-2010 NHANES also employs a complex sampling strategy to obtain a 
representative sample of the U.S. civilian, non-institutionalized population ages two months 
and older. African-Americans and Mexican-Americans are over-sampled. Response rates for 
the household interview ranged from 81.9% to 85.6% in the NHANES III and the 
1999-2008 NHANES. Data from NHANES 2009-2010 are projected to be publically 
available for analysis and inclusion into future studies in 2012. Upon release of these data, 
which will include serum cotinine, total urinary NNAL measurements, and chronic 
respiratory disease measures, they can be included in research for addressing symptoms, 
diagnoses and tests of CRDs and assessment of SHS exposure resulting in further increase in 
the sample size. The NHANES survey combines interviews and physical examinations 
across multiple years. Anonymous survey data and related documents can be obtained from 
http://www.cdc.gov/nchs/nhanes.htm.
Tobacco-related measurements
Assessment of tobacco smoking status and tobacco smoke exposure can be assessed in both 
NHANES III and the continuous NHANES. Survey participants are asked about current and 
past tobacco use as well as exposure to second hand smoke exposure at home or at the 
workplace. The self-report variables of tobacco smoke exposure can be used independently 
or in combination with objective measures of recent tobacco smoke exposure with serum 
cotinine and NNAL measurements.
Serum cotinine is available for NHANES III participants aged 4 years old and above. The 
NHANES 1999-2010 contain serum cotinine measurements for participants aged 3 years old 
and above. In both surveys, serum cotinine was assessed using an isotope dilution, high 
performance liquid chromatography/atmospheric pressure chemical ionization tandem mass 
spectrometric method. The laboratory test detection limit for serum cotinine was 0.05ng/mL 
for NHANES III, NHANES 1999-2000, and part of NHANES 2001-2002. Improvements in 
the laboratory testing methods reduced the limit of detection (LOD) to 0.015ng/mL and this 
lower detection limit was used for NHANES 2001-2010. Urinary total NNAL testing was 
added to the series of laboratory tests in NHANES 2007-2008 and is also being collected in 
NHANES 2009-2010. NNAL is measured by using liquid chromatography linked to tandem 
mass spectroscopy. The laboratory test detection limit for urinary NNAL was 0.0006ng/mL. 
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In all studies, survey questions assessed for participant’s current or former use of all tobacco 
products as well as workplace and household SHS exposure.
Respiratory disease measurements
Similarly to the assessment of tobacco smoke exposure, NHANES III and the continuous 
NHNAES include self-report and more objective measures of CRDs. Survey questions 
regarding current and past diagnosis of asthma, chronic bronchitis, emphysema, and hay 
fever were included in both NHANES III and NHANES 1999-2008. Survey questions about 
sinusitis were asked in NHANES III, as well as in a battery of questions within a special 
NHANES 2005-2006 study on allergies. Respiratory outcome definitions requires 
consultation with respiratory disease experts and an updated review of any published 
NHANES studies which have used the respiratory-related data in this survey. For example, 
acute sinusitis can be defined as anyone who reports having 1 to 3 episodes of sinusitis or 
sinus problems over the past 12 months and chronic sinusitis is anyone who had at least 4 
episodes of continuous sinus problems during the past 12 months, as used elsewhere. In 
other cases the questions of doctor-defined respiratory conditions such as bronchitis can be 
used. Physical examination and laboratory variables for this analysis include spirometry, as 
well as serum total and allergen-specific IgE testing. Spirometry was performed on 20,627 
survey participants aged 8 years and older as part of NHANES III using equipment and 
procedures that met the 1987 American Thoracic Society’s recommendations using a 
minimum of five maneuvers. Analyses involving pulmonary function can be performed in 
participants with asthma or COPD. As part of the NHANES 2005-2006 special study, 
laboratory testing of total and allergen-specific serum IgE was performed on participants 
aged one year and older using the Pharmacia Diagnostics ImmunoCAP 1000 system 
(Kalamazoo, Michigan); these measures can also be evaluated.
Results
This study provides a general review of already-released and soon-to-be released data from 
the NHANES for symptoms, diagnoses and tests of CRDs and assessment of SHS exposure. 
We provided summaries of the data including the number of responders and the variables 
that can be used to study symptoms, diagnoses and tests of CRD and assessment of SHS 
exposure.
The current availability of reported SHS exposures, serum cotinine, total urinary NNAL, and 
corresponding LOD were provided for NHANES III and NHANES 1999-2008. Table 1 
provides a matrix of currently available NHANES biomarker and self-reported SHS data; in 
total, there are 61,261 serum cotinine measurements, 7,170 urinary NNAL measurements, 
and 85,617 survey responses regarding SHS exposure in all NHANES excluding NHANES 
2009-2010 which are projected to be publically available for analysis and inclusion into 
future studies in 2012. Of note, the percentages of serum cotinine values below the LOD 
range from 12.3% to 37.7%. The lowest percentage (12.3%) was seen between 1988-1994 
from NHANES III i.e. 2,751 out of 22,377 participants with serum cotinine values below 
0.005 ng/ml. On the other hand, the highest percentage (37.7%) was seen in the NHANES 
1999-2000 (i.e. 2,743 out of 7,284 participants with serum cotinine values below 0.05ng/
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ml). This low percentage of undetectable cotinine levels in the USA population in past years 
is likely due to implementation of stricter SHS exposure laws.
Symptoms, diagnoses and tests of CRDs such as asthma, chronic obstructive pulmonary 
diseases (bronchitis, chronic bronchitis, and emphysema), allergic rhinitis, hay fever and 
chronic sinusitis currently available in NHANES. Note that the NHANES 2005-2006 survey 
cycle conducted special testing regarding allergies and survey questions regarding allergic 
rhinitis and sinusitis. Table 2 presents a summary of the number of participants who were 
administered questions or laboratory testing involving CRD variables. Survey participants 
were asked whether they have ever been told by a doctor about having a current or past 
diagnosis of asthma, chronic bronchitis, emphysema, hay fever, and chronic sinusitis.
NHANES data (NHANES III 1988-1994, 1999-2010) can be utilized to explore a variety of 
issues related to the assessment of SHS and its relation to health outcomes for symptoms, 
diagnoses and tests of CRDs. NHANES provides population based data that is rich and cost 
effective in availability of the variables for studying SHS and CRD.
Acknowledgements
This work was supported by the Flight Attendant Medical Research Institute (FAMRI) Clinical Innovator Awards 
to Dr. Koru-Sengul and Dr. Lee, the National Institute of Environmental Health Sciences (NIH F30 ES015969) to 
Dr. Clark, the National Institute for Occupational Safety and Health grants (R01 OH003915) to Dr. Fleming and 
Dr. Lee, and the European Union Convergence funding to Dr. Fleming. The content is solely the responsibility of 
the authors and does not necessarily represent the official views of any of the Institutes.
References
1. Daher M. Overview of the World Health Report 2000 Health Systems: Improving Performance. J 
Med Liban. 2001; 49:22–24. [PubMed: 11910962] 
2. DeFrances CJ, Lucas CA, Buie VC, Golosinskiy A. 2006 National Hospital Discharge Survey. Natl 
Health Stat Report. 2008; 5:1–20. [PubMed: 18841653] 
3. Pitts SR, Niska RW, Xu J, Burt CW. National Hospital Ambulatory Medical Care Survey: 2006 
Emergency Department Summary. Natl Health Stat Report. 2008; 7:1–38. [PubMed: 18958996] 
4. Ebbert JO, Croghan IT, Schroeder DR, Murawski J, Hurt RD. Association between respiratory tract 
diseases and secondhand smoke exposure among never smoking flight attendants: a cross-sectional 
survey. Environ Health. 2007; 6:28. [PubMed: 17897468] 
5. WHO strategy for prevention and control of chronic respiratory diseases. World Health 
Organization Management of Noncommunicable Diseases Department. 2002. 
6. Segala C, Poizeau D, Neukirch F, Aubier M, Samson J, et al. Air pollution, passive smoking, and 
respiratory symptoms in adults. Arch Environ Health. 2004; 59:669–676. [PubMed: 16789476] 
7. Eisner MD. Environmental tobacco smoke exposure and pulmonary function among adults in 
NHANES III: impact on the general population and adults with current asthma. Environ Health 
Perspect. 2002; 110:765–770. [PubMed: 12153756] 
8. Jindal SK, Gupta D, Singh A. Indices of morbidity and control of asthma in adult patients exposed 
to environmental tobacco smoke. Chest. 1994; 106:746–749. [PubMed: 8082352] 
9. Sippel JM, Pedula KL, Vollmer WM, Buist AS, Osborne ML. Associations of smoking with 
hospitalbased care and quality of life in patients with obstructive airway disease. Chest. 1999; 
115:691–696. [PubMed: 10084477] 
10. Lieu JE, Feinstein AR. Confirmations and surprises in the association of tobacco use with sinusitis. 
Arch Otolaryngol Head Neck Surg. 2000; 126:940–946. [PubMed: 10922224] 
11. Arheart KL, Lee DJ, Fleming LE, LeBlanc WG, Dietz NA, et al. Accuracy of Self-Reported 
Smoking and Secondhand Smoke Exposure in the US Workforce: The National Health and 
Koru-Sengul et al. Page 6













Nutrition Examination Surveys. J Occup Environ Med. 2008; 50:1414–1420. [PubMed: 
19092497] 
Koru-Sengul et al. Page 7

























Koru-Sengul et al. Page 8
Table 1















Serum cotinine limit of 
detection (ng/mL) 0.050 0.050 0.050 or 0.015 0.015 0.015 0.015
# of participants with 
serum cotinine values 22,377 7,284 8,299 7,792 7,761 7,748
Serum cotinine values 
below the LOD (%) 2,751 (12.3%) 2,743 (37.7%) 1,872 (22.6%) 1,314 (16.9%) 1,368 (17.6%) 1,352 (17.5%)
Total Urine NNAL 
limit of detection 
(ng/mL)
- - - - - 0.0006
# of participants with 
total urine NNAL 
values
- - - - - 7,170
Total urine NNAL 
values below the LOD 
(%)
- - - - - 3172 (44.2%)
# of participants asked 
about workplace &
household SHS smoke 
exposures
33,994 9,965 11,039 10,122 10,348 10,149
Total Urinary NNAL, and corresponding Limits of Detection (LOD)
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Table 2
Symptoms, diagnoses and tests of chronic respiratory diseases (CRDs) currently available in the National 
Health and Nutrition Examination Survey (NHANES). Note that the NHANES 2005-2006 survey cycle 
conducted special testing regarding allergies and survey questions regarding allergic rhinitis and sinusitis.
Number of respondents












Subjects asked if ever been told you have asthma? 20,050 49,096 -
Subjects asked if still have asthma? 1,377 4,664 -
Subject asked if had asthma attack in past year? - 4,276 -
Emergency care visit for asthma/past year? - 2,198 -
Chronic Obstructive Pulmonary Disease
Subjects asked if a doctor ever told you that you have chronic bronchitis? 20,050 26,249 -
Subject asked if still have chronic bronchitis? - 1,211 -
Subjects asked if still have bronchitis? 1,134 - -
Subjects asked if a doctor ever told you that you have emphysema? 20,050 26,243 -
Allergic Rhinitis
Serum Total IgE and allergen specific IgE - - 8,336
Subject asked if a doctor every told you that you have allergies? - - 9,822
Subjects asked it a doctor ever told you that you have hay fever? 20,050 - 9,822
Subjects asked if still have hay fever? 1,501 - -
Subject asked if had hay fever in past year? - 14,920 -
Chronic Sinusitis
During the past 12 months, have you had sinusitis or sinus problems? 5,848 - -
Number of episodes of sinusitis in the past 12 months? 4,526 - -
Subject asked if during last 12 months a doctor told you that you have sinus 
infection?
- - 9,822
Subject asked if currently has flu, pneumonia, ear infection? - 45,061 -
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